Nuvectis Pharma, Inc. · NASDAQ:NVCT
Kaplan Matthew L. received 35,000 Nuvectis Pharma, Inc. shares as an award (Form 4)
Traded Jun 11, 2026 · Filed Jun 12, 2026
On Jun 11, 2026, Kaplan Matthew L. (Director) received 35,000 Nuvectis Pharma, Inc. shares as an award, leaving 159,760 shares. Filed Jun 12, 2026 (Form 4).
- Awarded
- 35,000 shares
- Holding after
- 159,760 shares
- Trading plan
- No
- Role
- Director
The filing in full
| Date | Security | Transaction | Shares | Price | Holding after | Ownership |
|---|---|---|---|---|---|---|
| Jun 11, 2026 | Common Stock | Award | 35,000 | 159,760 | Direct |